Compound ID | 1504
Class: Nitroimidazole
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Targets electron transport proteins; reduced to toxic free-radicals inside cells which reacts to damage DNA |
| Target Pathogen: | Active against Clostridium difficile and Fusobacterium; only effective against anaerobic bacteria |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 1960 |
| Highest development stage: | Approved by FDA in 1995 |
| Development status: | Approved |
| Reason dropped: | Other formulations were discontinued |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/4173 |
| Guide to Pharmacology: | metronidazole |
| Citations: |
|